Adjuvant Global Health Technology Fund, L.P.

13D and 13G Filings

13D/G filings
13G on 1 security
Location
New York, NY
CIK
0001783165
Form D filings
3 filings
All SEC filings
View on sec.gov
Issuer % of Class Filed
Schedule 13G · 1 security · passive
AN2 Therapeutics, Inc. 13G/A
ANTX · 037326105
7.9% 2/28/2025
Event 12/31/2024

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.